Literature DB >> 16969092

E1B55K-deleted adenovirus (ONYX-015) overrides G1/S and G2/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells.

Gioia Cherubini1, Tatiana Petouchoff, Milena Grossi, Stefania Piersanti, Enrico Cundari, Isabella Saggio.   

Abstract

In order to take advantage of cell replication machinery, viruses have evolved complex strategies to override cell cycle checkpoints and force host cells into S phase. To do so, virus products must interfere not only with the basal cell cycle regulators, such as pRb or Mad2, but also with the main surveillance pathways such as those controlled by p53 and ATM. Recently, a number of defective viruses has been produced which, lacking the latter ability, are incapable of replicating in normal cells but should be able to grow and finally lyse those cells that, such as the tumor cells, have lost their surveillance mechanisms. A prototype of these oncolytic viruses is the E1B55K-defective Adenovirus ONYX-015, which was predicted to selectively replicate and kill p53-deficient cancer cells. We found that, despite wt p53 and notwithstanding the activation of the checkpoint regulators p53, ATM and Mad2, ONYX-015 actively replicated in HUVEC cells. Furthermore, ONYX-015 replication induced a specific phenotype, which is distinct from that of the E4-deleted adenovirus dlE4 Ad5, although both viruses express the main regulatory region E1A. This phenotype includes overriding of the G(1)/S and G(2)/M checkpoints, over-expression of MAD2 and retardation of mitosis and accumulation of polyploid cells, suggesting the occurrence of alterations at the mitotic-spindle checkpoint and impairment of the post-mitotic checkpoint. Our data suggest that viral E1A and E4 region products can override all host cell-checkpoint response even at the presence of a full activation of the ATM/p53 pathway. Furthermore, the E4 region alone seems to act independently of the E1B55K virus product in impairing the ATM-dependent, p53-independent G(2)/M checkpoint since dlE4 Ad5-infected cells arrested in G(2) while ONYX-015-infected cells did enter mitosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969092     DOI: 10.4161/cc.5.19.3263

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  25 in total

1.  Adenovirus E1A oncogene induces rereplication of cellular DNA and alters DNA replication dynamics.

Authors:  Ghata Singhal; Elisabetta Leo; Saayi Krushna Gadham Setty; Yves Pommier; Bayar Thimmapaya
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

2.  A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells.

Authors:  Guangyu Ma; Boya Zhong; Shinya Okamoto; Yuanyuan Jiang; Kiyoko Kawamura; Hongdan Liu; Quanhai Li; Masato Shingyoji; Ikuo Sekine; Yuji Tada; Koichiro Tatsumi; Hideaki Shimada; Kenzo Hiroshima; Masatoshi Tagawa
Journal:  Tumour Biol       Date:  2015-05-20

Review 3.  p53 gene in treatment of hepatic carcinoma: status quo.

Authors:  Yong-Song Guan; Zi La; Lin Yang; Qing He; Ping Li
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

4.  Adenovirus replaces mitotic checkpoint controls.

Authors:  Roberta L Turner; Peter Groitl; Thomas Dobner; David A Ornelles
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

5.  A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.

Authors:  Neda Bagheri; Marisa Shiina; Douglas A Lauffenburger; W Michael Korn
Journal:  PLoS Comput Biol       Date:  2011-02-17       Impact factor: 4.475

6.  Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells.

Authors:  Y Takei; S Okamoto; K Kawamura; Y Jiang; T Morinaga; M Shingyoji; I Sekine; S Kubo; Y Tada; K Tatsumi; H Shimada; K Hiroshima; N Yamaguchi; M Tagawa
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

7.  Widespread phosphorylation of histone H2AX by species C adenovirus infection requires viral DNA replication.

Authors:  Gena J Nichols; Jerome Schaack; David A Ornelles
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection.

Authors:  Hideyo Ugai; Minghui Wang; Long P Le; David A Matthews; Masato Yamamoto; David T Curiel
Journal:  J Mol Biol       Date:  2009-10-21       Impact factor: 5.469

9.  RAD51 and BRCA2 Enhance Oncolytic Adenovirus Type 5 Activity in Ovarian Cancer.

Authors:  Laura A Tookman; Ashley K Browne; Claire M Connell; Gemma Bridge; Carin K Ingemarsdotter; Suzanne Dowson; Atsushi Shibata; Michelle Lockley; Sarah A Martin; Iain A McNeish
Journal:  Mol Cancer Res       Date:  2015-10-09       Impact factor: 5.852

10.  Global analysis of Arabidopsis gene expression uncovers a complex array of changes impacting pathogen response and cell cycle during geminivirus infection.

Authors:  José Trinidad Ascencio-Ibáñez; Rosangela Sozzani; Tae-Jin Lee; Tzu-Ming Chu; Russell D Wolfinger; Rino Cella; Linda Hanley-Bowdoin
Journal:  Plant Physiol       Date:  2008-07-23       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.